.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Express Scripts
Moodys
Dow
Cerilliant
Deloitte
Fish and Richardson
McKesson
Johnson and Johnson
Argus Health

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,074,668

« Back to Dashboard

Which drugs does patent 6,074,668 protect, and when does it expire?


Patent 6,074,668 protects ULTANE and is included in one NDA.

Protection for ULTANE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has forty-one patent family members in thirty-four countries.

Summary for Patent: 6,074,668

Title: Container for an inhalation anesthetic
Abstract:A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing polyethylene napthalate. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
Inventor(s): Flament-Garcia; Mary Jane (Gurnee, IL), Chang; Steve H. (Gurnee, IL), Cromack; Keith R. (Lake Bluff, IL), Garapolo; Joan (Libertyville, IL), Loffredo; David (Elmhurst, IL), Raghavan; Rajagopalan (Grayslake, IL), Ramsay; George M. (Waukegan, IL), Rice; Patrick (Waukegan, IL), Setesak; Jeffrey (Lincolnshire, IL)
Assignee: Abbott Laboratories (Abbott Park, IL)
Application Number:09/004,876
Patent Claim Types:
see list of patent claims
Compound; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Abbvie
ULTANE
sevoflurane
LIQUID;INHALATION020478-001Jun 7, 1995ANRXYesYes6,074,668*PED► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 6,074,668

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,083,514 Polymethylpentene container for an inhalation anesthetic► Subscribe
6,558,679 Container for an inhalation anesthetic► Subscribe
6,162,443 Container for an inhalation anesthetic► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 6,074,668

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Turkey200001695► Subscribe
Slovakia285437► Subscribe
Slovakia10462000► Subscribe
Slovenia1045686► Subscribe
Russian Federation2207105► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Cerilliant
Dow
Teva
UBS
McKinsey
QuintilesIMS
Argus Health
Daiichi Sankyo
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot